Acute rejection · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
New onset of diabetes · adult patients with malnutrition and encephalopathy before and after liver transplantation.
It is very uncertain whether hepatic product (HepaticAid) changes new onset of diabetes compared with diet only (without supplement) (very low certainty).
1 finding from 1 review
Length of hospital stay after liver transplantation [days] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Hepatic encephalopathy related hospitalisation · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Changes in grade of hepatic encephalopathy [grade 0‐4] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Re‐hospitalisation post liver transplantation [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Infections [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation.
1 finding from 1 review
Open reduction and fixation vs Closed (conservative) management (no active intervention other than soft diet, analgesics or antibiotics; or intermaxillary/maxillary-mandibular fixation with rigid or elastic traction)
Outcome not reported · Adults, over 18 years of age, with unilateral or bilateral fractures of the mandibular condyles
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
0 studies
No studies found
Intervention not reported
All‐cause mortality · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events at longest · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with gallstone disease (cholesterol, pigment, or mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Systolic blood pressure · patients with diabetes with or without CKD
3 findings from 1 review
no estimate extracted
7 studies · 288 participants
Low
no estimate extracted
5 studies · 112 participants
Low
no estimate extracted
5 studies · 108 participants
Low
MAP Duration: up to 12 weeks · patients with diabetes with or without CKD
2 findings from 1 review
Diastolic blood pressure · patients with diabetes with or without CKD
3 findings from 1 review
no estimate extracted
7 studies · 288 participants
Low
no estimate extracted
5 studies · 112 participants
Low
no estimate extracted
5 studies · 108 participants
Low
GFF: all studies Duration: up to 12 weeks · patients with diabetes with or without CKD
1 finding from 1 review
Weight (kg) · patients with diabetes with or without CKD
1 finding from 1 review
Intervention not reported
Gestational diabetes mellitus · pregnant women (women with pre‐existing type 1 or type 2 diabetes are NOT included)
It is very uncertain whether the intervention changes gestational diabetes mellitus (very low certainty).
1 finding from 1 review
Intervention not reported
Composite of serious neonatal outcomes · infants of pregnant women
1 finding from 1 review
Intervention not reported
Neonatal hypoglycaemia · infants of pregnant women
It is very uncertain whether the intervention changes neonatal hypoglycaemia (very low certainty).
1 finding from 1 review
Intervention not reported
Adiposity · infants of pregnant women
1 finding from 1 review